Chimeric	O
EWSR1	O
-	O
FLI1	O
regulates	O
the	O
Ewing	B-DISEASE
sarcoma	E-DISEASE
susceptibility	O
gene	O
EGR2	O
via	O
a	O
GGAA	O
microsatellite	O
.	O


Deciphering	O
the	O
ways	O
in	O
which	O
somatic	O
mutations	O
and	O
germline	O
susceptibility	O
variants	O
cooperate	O
to	O
promote	O
cancer	S-DISEASE
is	O
challenging	O
.	O
Ewing	B-DISEASE
sarcoma	E-DISEASE
is	O
characterized	O
by	O
fusions	O
between	O
EWSR1	O
and	O
members	O
of	O
the	O
ETS	O
gene	O
family	O
,	O
usually	O
EWSR1	O
-	O
FLI1	O
,	O
leading	O
to	O
the	O
generation	O
of	O
oncogenic	O
transcription	O
factors	O
that	O
bind	O
DNA	O
at	O
GGAA	O
motifs	O
.	O


A	O
recent	O
genome	O
-	O
wide	O
association	O
study	O
identified	O
susceptibility	O
variants	O
near	O
EGR2	O
.	O


Here	O
we	O
found	O
that	O
EGR2	O
knockdown	O
inhibited	O
proliferation	O
,	O
clonogenicity	O
and	O
spheroidal	O
growth	O
in	O
vitro	O
and	O
induced	O
regression	O
of	O
Ewing	B-DISEASE
sarcoma	E-DISEASE
xenografts	O
.	O


Targeted	O
germline	O
deep	O
sequencing	O
of	O
the	O
EGR2	O
locus	O
in	O
affected	O
subjects	O
and	O
controls	O
identified	O
291	O
Ewing	O
-	O
associated	O
SNPs	O
.	O


At	O
rs79965208	O
,	O
the	O
A	O
risk	O
allele	O
connected	O
adjacent	O
GGAA	O
repeats	O
by	O
converting	O
an	O
interspaced	O
GGAT	O
motif	O
into	O
a	O
GGAA	O
motif	O
,	O
thereby	O
increasing	O
the	O
number	O
of	O
consecutive	O
GGAA	O
motifs	O
and	O
thus	O
the	O
EWSR1	O
-	O
FLI1	O
-	O
dependent	O
enhancer	O
activity	O
of	O
this	O
sequence	O
,	O
with	O
epigenetic	O
characteristics	O
of	O
an	O
active	O
regulatory	O
element	O
.	O


EWSR1	O
-	O
FLI1	O
preferentially	O
bound	O
to	O
the	O
A	O
risk	O
allele	O
,	O
which	O
increased	O
global	O
and	O
allele	O
-	O
specific	O
EGR2	O
expression	O
.	O


Collectively	O
,	O
our	O
findings	O
establish	O
cooperation	O
between	O
a	O
dominant	O
oncogene	O
and	O
a	O
susceptibility	O
variant	O
that	O
regulates	O
a	O
major	O
driver	O
of	O
Ewing	B-DISEASE
sarcomagenesis	E-DISEASE
.	O
